MedTrace Logo

Cognitive Effects Associated With Hippocampal Neurogenesis Induced by ECT in the Treatment of Depression

NCT06661616 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2024-10-28

No results posted yet for this study

Summary

Electroconvulsive therapy (ECT) is the treatment of choice for drug-resistant depression (30% of patients), or when there is a short-term risk to the patient's life. Despite its robust efficacy and rapid onset of action, its use is limited both by the limited range of treatment available and by the cognitive effects sometimes induced. The present study focuses on the links between the efficacy of ECT, its cognitive effects and the formation of new neurons in the hippocampus (hippocampal neurogenesis) associated with this treatment.

Conditions

  • Major Depressive Disorder (MDD)
  • Bipolar Disorder Depression

Sponsors & Collaborators

  • Centre Hospitalier St Anne

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-06
Primary Completion
2024-05-14
Completion
2024-05-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06661616 on ClinicalTrials.gov